A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2002
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002	WO2002064591A3 Carboline derivatives
12/12/2002	WO2002064552A8 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
12/12/2002	WO2002064089A3 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002060533A3 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
12/12/2002	WO2002036163A3 Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses
12/12/2002	WO2002032898A3 Novel anticholinergics, method for the production thereof and use thereof as medicaments
12/12/2002	WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002	WO2001097786A3 Benzothiazole derivatives
12/12/2002	WO2001095922A1 Remedies for allergic diseases and process for producing the same
12/12/2002	US20020188281 Stabilized bioactive preparations and method of use
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188118 Compounds and methods for the inhibition of the expression of VCAM-1
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187989 Preventive or therapeutic drugs for various eosinophilia-related diseases containg chymase inhibitors as the active ingredient
12/12/2002	US20020187947 Inflammation-related gene
12/12/2002	US20020187941 Pregabalin lactose conjugates
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187473 Polyamide nucleic acid derivatives, and agents and processes for preparing them
12/12/2002	US20020187105 Polymer combinations that result in stabilized aerosols for gene delivery to the lungs
12/12/2002	CA2464511A1 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449095A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	CA2412652A1 Remedies for allergic diseases and process for producing the same
12/11/2002	WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263443A1 Metalloproteinase inhibitors for the treatment of respiratoty diseases
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263422A1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd)
12/11/2002	EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0923568B1 Novel benzofuran-4-carboxamides
12/11/2002	EP0873337B1 Salts of n-(4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
12/11/2002	CN1384883A Production of recombinant respiratory syncytical viruses expressing immune modulatory molecules
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist
12/11/2002	CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors
12/11/2002	CN1384740A Delayed-action form of administration containing tramadol saccharinate
12/11/2002	CN1384739A Oral pharmaceutical forms of administration with a delayed action
12/11/2002	CN1384735A Oral dosage forms
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1383883A Chinese medicine for treating pharyngitis and globus hystericus and its prepn
12/11/2002	CN1383865A Medicine for treating acute and chronic pharyngitis and its prepn
12/11/2002	CN1383863A Medicine for treating cough and asthma and its prepn
12/11/2002	CN1383859A Health tea
12/11/2002	CN1383823A Method of applying MEK inhibitor to treat or inhibit neutrophil chemotaxis
12/11/2002	CN1095834C Quinolinone derivatives and antianaphylactic agent containing said quinolinone derivative as biological active component
12/11/2002	CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/10/2002	US6492552 Disulfide derivatives useful for treating allergic diseases

1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 878